These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24504378)

  • 1. Renal tubular dysfunction in sickle cell disease.
    Silva Junior GB; Vieira AP; Couto Bem AX; Alves MP; Meneses GC; Martins AM; Sanches TR; Andrade LC; Seguro AC; Libório AB; Daher EF
    Kidney Blood Press Res; 2013; 38(1):1-10. PubMed ID: 24504378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in hepatosplenic schistosomiasis--an assessment of renal tubular disorders.
    Duarte DB; Vanderlei LA; Bispo RK; Pinheiro ME; da Silva GB; Martins AM; Meneses GC; Daher Ede F
    PLoS One; 2014; 9(12):e115197. PubMed ID: 25531759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular dysfunction in children with sickle cell haemoglobinopathy.
    Badr M; El Koumi MA; Ali YF; El-Morshedy S; Almonem NA; Hassan T; El Rahman RA; Afify M
    Nephrology (Carlton); 2013 Apr; 18(4):299-303. PubMed ID: 23432792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular Acidification Defect in Adults with Sickle Cell Disease.
    Cazenave M; Audard V; Bertocchio JP; Habibi A; Baron S; Prot-Bertoye C; Berkenou J; Maruani G; Stehlé T; Cornière N; Ayari H; Friedlander G; Galacteros F; Houillier P; Bartolucci P; Courbebaisse M
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):16-24. PubMed ID: 31822527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular dysfunction in patients with American cutaneous leishmaniasis.
    Oliveira RA; Diniz LF; Teotônio LO; Lima CG; Mota RM; Martins A; Sanches TR; Seguro AC; Andrade L; Silva GB; Libório AB; Daher EF
    Kidney Int; 2011 Nov; 80(10):1099-106. PubMed ID: 21814169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of indomethacin on renal concentrating and diluting capacity in sickle cell nephropathy.
    De Jong PE; De Jong-van den Berg LT; De Zeeuw D; Donker AJ; Schouten H; Statius van Eps LW
    Clin Sci (Lond); 1982 Jul; 63(1):53-8. PubMed ID: 7083765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy.
    da Silva GB; Libório AB; Daher Ede F
    Ann Hematol; 2011 Dec; 90(12):1371-9. PubMed ID: 21901339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spectrum of renal manifestations in sickle cell disease].
    Cazenave M; Koehl B; Nochy D; Tharaux PL; Audard V
    Nephrol Ther; 2014 Feb; 10(1):10-6. PubMed ID: 24113202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal abnormalities in sickle cell disease.
    Allon M
    Arch Intern Med; 1990 Mar; 150(3):501-4. PubMed ID: 2178577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glomerular function and urine acidification in chronic renal diseases].
    Mizukami K
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):1-11. PubMed ID: 2161472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on sickle cell nephropathy.
    Alhwiesh A
    Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):249-65. PubMed ID: 24625990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of glomerular dysfunction and renal tubulopathy in children with sickle cell disease in India.
    Karapurkar S; Ghildiyal R; Shah N; Keshwani R; Sharma S
    J Trop Pediatr; 2023 Feb; 69(2):. PubMed ID: 37004730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of renal tubular functions in convalescent phase of hemorrhagic fever with renal syndrome.
    Kim GH; Han JS; Earm J; Jeon US; Kim YS; Ahn C; Kim S; Lee JS
    Am J Nephrol; 1998; 18(2):123-30. PubMed ID: 9569954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary endothelin-1 as a marker of renal damage in sickle cell disease.
    Tharaux PL; Hagège I; Placier S; Vayssairat M; Kanfer A; Girot R; Dussaule JC
    Nephrol Dial Transplant; 2005 Nov; 20(11):2408-13. PubMed ID: 16144850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
    Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of renal function in leprosy: a study of 59 consecutive patients.
    Oliveira RA; Silva GB; Souza CJ; Vieira EF; Mota RM; Martins AM; Libório AB; Daher EF
    Nephrol Dial Transplant; 2008 Jan; 23(1):256-62. PubMed ID: 17901068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal abnormalities in sickle cell disease.
    Ataga KI; Orringer EP
    Am J Hematol; 2000 Apr; 63(4):205-11. PubMed ID: 10706765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.
    Silva Junior GB; Vieira AP; Couto Bem AX; Alves MP; Meneses GC; Martins AM; Araújo SM; Libório AV; Daher EF
    Int J Clin Pharm; 2014 Aug; 36(4):766-70. PubMed ID: 24934760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.
    Hariri E; Mansour A; El Alam A; Daaboul Y; Korjian S; Aoun Bahous S
    Int Urol Nephrol; 2018 Jun; 50(6):1075-1083. PubMed ID: 29383580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.